Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313252357> ?p ?o ?g. }
- W4313252357 endingPage "100596" @default.
- W4313252357 startingPage "100596" @default.
- W4313252357 abstract "Autosomal dominant polycystic kidney disease (ADPKD) is part of a spectrum of inherited diseases that also includes autosomal recessive polycystic kidney disease, autosomal dominant polycystic liver disease, and an expanding group of recessively inherited disorders collectively termed hepatorenal fibrocystic disorders. ADPKD is the most common monogenic disorder frequently leading to chronic kidney failure with an estimated prevalence of 12 million people worldwide. Currently, only one drug (tolvaptan) has been approved by regulatory agencies as disease-modifying therapy for ADPKD, but, given its mechanism of action and side effect profile, the need for an improved therapy for ADPKD remains a priority. Although significant regulatory progress has been made, with qualification of total kidney volume as a prognostic enrichment biomarker and its later designation as a reasonably likely surrogate endpoint for progression of ADPKD within clinical trials, further work is needed to accelerate drug development efforts for all forms of PKD. In May 2021, the PKD Outcomes Consortium at the Critical Path Institute and the PKD Foundation organized a PKD Regulatory Summit to spur conversations among patients, industry, academic, and regulatory stakeholders regarding future development of tools and drugs for ADPKD and autosomal recessive polycystic kidney disease. This Special Report reviews the key points discussed during the summit and provides future direction related to PKD drug development tools." @default.
- W4313252357 created "2023-01-06" @default.
- W4313252357 creator A5033044142 @default.
- W4313252357 creator A5043321373 @default.
- W4313252357 creator A5053746373 @default.
- W4313252357 creator A5064202053 @default.
- W4313252357 creator A5085269683 @default.
- W4313252357 date "2023-03-01" @default.
- W4313252357 modified "2023-09-28" @default.
- W4313252357 title "Polycystic Kidney Disease Drug Development: A Conference Report" @default.
- W4313252357 cites W1818809792 @default.
- W4313252357 cites W1970336842 @default.
- W4313252357 cites W1982151472 @default.
- W4313252357 cites W1989864848 @default.
- W4313252357 cites W1996820729 @default.
- W4313252357 cites W1997286719 @default.
- W4313252357 cites W1997532257 @default.
- W4313252357 cites W2015774770 @default.
- W4313252357 cites W2015846801 @default.
- W4313252357 cites W2016615097 @default.
- W4313252357 cites W2055919784 @default.
- W4313252357 cites W2061060689 @default.
- W4313252357 cites W2070934072 @default.
- W4313252357 cites W2078896707 @default.
- W4313252357 cites W2079838350 @default.
- W4313252357 cites W2101067234 @default.
- W4313252357 cites W2102078026 @default.
- W4313252357 cites W2116811919 @default.
- W4313252357 cites W2129253605 @default.
- W4313252357 cites W2136068783 @default.
- W4313252357 cites W2138059729 @default.
- W4313252357 cites W2138477603 @default.
- W4313252357 cites W2152166772 @default.
- W4313252357 cites W2155089160 @default.
- W4313252357 cites W2160799564 @default.
- W4313252357 cites W2162269191 @default.
- W4313252357 cites W2292155255 @default.
- W4313252357 cites W2342344974 @default.
- W4313252357 cites W2359535866 @default.
- W4313252357 cites W2466735922 @default.
- W4313252357 cites W2504200505 @default.
- W4313252357 cites W2522603771 @default.
- W4313252357 cites W2577378324 @default.
- W4313252357 cites W2583311472 @default.
- W4313252357 cites W2586813559 @default.
- W4313252357 cites W2590701129 @default.
- W4313252357 cites W2609956105 @default.
- W4313252357 cites W2766704070 @default.
- W4313252357 cites W2769033438 @default.
- W4313252357 cites W2769726366 @default.
- W4313252357 cites W2781941362 @default.
- W4313252357 cites W2802795115 @default.
- W4313252357 cites W2886899199 @default.
- W4313252357 cites W2906737259 @default.
- W4313252357 cites W2907305153 @default.
- W4313252357 cites W2908078805 @default.
- W4313252357 cites W2922441540 @default.
- W4313252357 cites W2925093743 @default.
- W4313252357 cites W2942607819 @default.
- W4313252357 cites W2945570232 @default.
- W4313252357 cites W2947194217 @default.
- W4313252357 cites W2980851407 @default.
- W4313252357 cites W3032821290 @default.
- W4313252357 cites W3034436041 @default.
- W4313252357 cites W3036571714 @default.
- W4313252357 cites W3040659673 @default.
- W4313252357 cites W3089719801 @default.
- W4313252357 cites W3123898773 @default.
- W4313252357 cites W3124864055 @default.
- W4313252357 cites W3127231889 @default.
- W4313252357 cites W3135355396 @default.
- W4313252357 cites W3147258246 @default.
- W4313252357 cites W3152017609 @default.
- W4313252357 cites W3159425157 @default.
- W4313252357 cites W3191658796 @default.
- W4313252357 cites W3210534416 @default.
- W4313252357 cites W4211149297 @default.
- W4313252357 cites W4292787727 @default.
- W4313252357 cites W4292850078 @default.
- W4313252357 cites W4292851097 @default.
- W4313252357 doi "https://doi.org/10.1016/j.xkme.2022.100596" @default.
- W4313252357 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36698747" @default.
- W4313252357 hasPublicationYear "2023" @default.
- W4313252357 type Work @default.
- W4313252357 citedByCount "1" @default.
- W4313252357 countsByYear W43132523572023 @default.
- W4313252357 crossrefType "journal-article" @default.
- W4313252357 hasAuthorship W4313252357A5033044142 @default.
- W4313252357 hasAuthorship W4313252357A5043321373 @default.
- W4313252357 hasAuthorship W4313252357A5053746373 @default.
- W4313252357 hasAuthorship W4313252357A5064202053 @default.
- W4313252357 hasAuthorship W4313252357A5085269683 @default.
- W4313252357 hasBestOaLocation W43132523571 @default.
- W4313252357 hasConcept C100773827 @default.
- W4313252357 hasConcept C121608353 @default.
- W4313252357 hasConcept C126322002 @default.
- W4313252357 hasConcept C177713679 @default.
- W4313252357 hasConcept C2776264508 @default.